Seres Therapeutics's total assets for Q1 2026 were $117.62M, a decrease of -14.89% from the previous quarter. DE:1S90 total liabilities were $91.12M for the fiscal quarter, a -3.04% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.